The upregulation of IDO in RSV-infected mesenchymal stem cells might affect immune cell proliferation, which might be responsible for the lack of protective immunity against RSV and for the long-term outcomes of RSV-induced lung diseases such as asthma and chronic obstructive pulmonary disease (42). This evidence concerns the gene IDO1 and lung disorder.